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Purpose: To determine the optimal peak systolic velocity (PSV) thresh-
old at duplex ultrasonography (US) required to establish the
need for carotid endarterectomy in symptomatic patients on
the basis of the long-term cost-effectiveness outcomes of
diagnostic testing and subsequent treatment.
Materials and
Methods:
From January 1997 through January 2000, a prospective
medical ethics committee–approved multicenter study was
conducted. After giving informed consent, patients with am-
aurosis fugax, transient ischemic attack, orminor strokewho
underwent duplex US and digital subtraction angiography
were included in the study. Selective ipsilateral carotid angio-
grams were obtained in at least three planes. Arteries that
were nearly or totally occluded at duplex US were excluded
because the PSV cannot be reliably measured in these ves-
sels. Receiver operating characteristic (ROC) curves were
constructed for the diagnoses of 70%–99% and 50%–99%
stenoses. Optimal likelihood ratios were calculated on the
basis of lifetime costs and quality-adjusted life-years derived
at cost-effectiveness analysis and the prevalence of disease.
The associated optimal sensitivities, specificities, and PSV
thresholds were derived from the ROC curves.
Results: In this clinical study, 350 patients were included. The nonoc-
cluded arteries in a total of 236 patients were assessable for
ROC analysis. For the diagnosis of 70%–99% stenosis, the
optimal likelihood ratio was 0.21, which was associated with
a PSV threshold of 220 cm/sec, a sensitivity of 97% (127 of
131 patients; 95% confidence interval [CI]: 94%, 100%), and
a specificity of 48% (50 of 105 patients; 95% CI: 38%, 57%).
For the diagnosis of 50%–99% stenosis, the optimal likeli-
hood ratio was 0.38, which was associated with a PSV
threshold of 180 cm/sec, a sensitivity of 95% (182 of 191
patients; 95% CI: 92%, 98%), and a specificity of 69% (31 of
45 patients; 95% CI: 55%, 82%).
Conclusion: On the basis of the lifetime outcomes of diagnostic testing
and subsequent treatment, the optimal PSV thresholds for
the diagnosis of 70%–99% and 50%–99% carotid artery
stenoses in patients with amaurosis fugax, transient ischemic
attack, or minor stroke were 220 cm/sec and 180 cm/sec,
respectively.
 RSNA, 2005
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The results of two large randomizedtrials—the North American Symp-tomatic Carotid Endarterectomy
Trial (NASCET) and the European Ca-
rotid Surgery Trial—have shown ca-
rotid artery endarterectomy to yield a
considerable benefit in patients with
70%–99% stenosis and a small benefit
in patients with 50%–69% stenosis (1–
6). In these trials, severe carotid artery
stenosis was diagnosed by using cere-
bral angiography, the reference-stan-
dard examination. However, cerebral
angiography is associated with a risk of
mortality and morbidity and a marked
financial cost. The routine use of cere-
bral angiography in patients with amau-
rosis fugax, transient ischemic attack,
or minor stroke who are potential end-
arterectomy candidates is therefore un-
desirable. Consequently, many clini-
cians now use noninvasive examinations
such as duplex ultrasonography (US),
magnetic resonance (MR) angiography,
and computed tomographic (CT) an-
giography to select patients for carotid
endarterectomy (7). In a cost-effective-
ness analysis, we recently found duplex
US to be the optimal test strategy for
selecting patients suitable for carotid
endarterectomy (8).
Moreover, the Society of Radiolo-
gists in Ultrasound (SRU) has published
recommendations for the interpretation
of duplex US results in the diagnosis of
internal carotid artery stenosis (7).
These recommendations are based on
the test characteristics and diagnostic
accuracy of duplex US reported in the
literature. In most of the diagnostic
studies reviewed by the SRU, the opti-
mal threshold of the peak systolic veloc-
ity (PSV) was based on the maximiza-
tion of diagnostic accuracy. With maxi-
mization of accuracy as a criterion, one
assumes that a false-negative test result
has the same importance as a false-pos-
itive result. However, because the du-
plex US result is used to determine
whether or not carotid endarterectomy
will be performed, the consequences of
missing a significant stenosis may be
more or less favorable in terms of cost
and/or effectiveness outcomes than the
consequences of performing endarter-
ectomy for a nonsignificant stenosis.
Therefore, it is more clinically relevant
to account for the costs and treatment
effectiveness associated with false-posi-
tive and false-negative test results when
selecting an optimal threshold for refer-
ring patients for endarterectomy.
Accordingly, the aim of our study
was to determine the optimal PSV
threshold at duplex US required to es-
tablish the need for carotid endarterec-
tomy in symptomatic patients on the ba-
sis of the long-term cost-effectiveness




From January 1997 through January
2000, a prospective diagnostic study
was performed at two academic hospi-
tals (University Medical Center Utrecht
and Erasmus MC-University Medical
Center Rotterdam) and one nonaca-
demic hospital (Medical Spectrum
Twente, Enschede, the Netherlands)
(9). In this study, 350 patients with a
mean age of 67 years (range, 39–88
years) were included and 76% (n 
266) of them were male (9). Two hun-
dred forty-nine of these subjects were
patients at University Medical Center
Utrecht, 62 were patients at Erasmus
MC-University Medical Center Rotter-
dam, and 39 were patients at Medical
Spectrum Twente. After giving in-
formed consent, patients with amauro-
sis fugax, transient ischemic attack, or
minor stroke underwent carotid duplex
US and carotid digital subtraction an-
giography (DSA) within a time frame of
4 weeks. The medical ethics committee
at each hospital approved the study.
Duplex US of Carotid Arteries
In the majority of patients (n  311
[89%]), duplex US was performed with
an Ultramark 9 HDI or HDI 3000 (Ad-
vanced Technology Laboratories, Both-
ell, Wash) machine. For the 39 remain-
ing patients, a Diasonics Master Series
(GE Medical Systems, Milwaukee, Wis)
unit was used. The Doppler angle was
aligned to the jet and kept below 60°.
The pulsed Doppler gate was positioned
in the center of the common carotid
artery, approximately 2 cm proximal to
the carotid artery bifurcation, and a
spectral waveform was obtained. Sub-
sequently, the area with the most se-
vere stenosis was located by using color
Doppler US, and a Doppler spectral
waveform was obtained at the point of
the greatest mean frequency shift. From
this spectrum, the PSV of the internal
carotid artery was derived. Duplex US
examinations were performed by quali-
fied vascular technologists in the vascu-
lar laboratory of each hospital. The PSV
was measured on a continuous scale, in
centimeters per second, in the proximal
region of the symptomatic internal ca-
rotid artery of each patient. A carotid
artery was deemed to be symptomatic
when the neurologic symptoms—specif-
ically, amaurosis fugax, transient ische-
mic attack, or minor stroke—corre-
sponded to the stenotic side. If no de-
tectable blood flow was present, the
patient was judged to have an occlu-
sion—that is, 100% stenosis. Slow flow
in combination with a visualized severe
stenosis was defined as near occlusion.
Arteries that were occluded or nearly
occluded at US were excluded from re-




CI  confidence interval
DSA  digital subtraction angiography
NASCET  North American Symptomatic Carotid
Endarterectomy Trial
NHB  net health benefit
PSV  peak systolic velocity
QALY  quality-adjusted life-year
ROC  receiver operating characteristic
SRU  Society of Radiologists in Ultrasound
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ceiver operating characteristic (ROC)
analysis, because PSV cannot reliably
be measured in these vessels.
DSA Examination
DSA was performed by using an Integris
V3000 or Poly-I (Philips Medical Sys-
tems, Best, the Netherlands) angio-
graphic unit with an image intensifier
matrix of 1024  1024. In eight pa-
tients, an Angiostar Plus (Siemens Med-
ical Systems, Forchheim, Germany)
unit was used. Selective positioning of
an intraarterial catheter in the common
carotid artery was performed by using
the Seldinger technique. From the ca-
rotid artery bifurcation, three projec-
tions (lateral, posteroanterior, and oblique)
were acquired. The additional projections
obtained at occasionally performed rota-
tional DSA examinations were not used in
this study. For each projection, 6 mL of
iopromide (Ultravist 300; Schering, Ber-
lin, Germany) was injected at a flow rate
of 3mL/sec or 9mL of iomeprol (Iomeron
350; Altana Pharma, Hoofddorp, the
Netherlands) was injected at a flow rate
of 6 mL/sec.
The DSA results were read by two
radiologists, each of whom had more
than 5 years of experience. The observ-
ers were blinded to the patients’ clinical
information and duplex US results.
They read the film hard copies of the
DSA images. The stenosis percentage
was measured according to NASCET
criteria (1). Degree of stenosis was de-
fined as the remaining lumen at the site
of the stenosis divided by the normal
lumen distal to the stenosis. Stenosis of
99% was defined as near occlusion. The
maximal degree of stenosis seen on the
three projections was used in the analy-
ses. DSA was considered the standard
of reference. Interobserver agreement
regarding data obtained in a represen-
tative sample of 170 patients was deter-
mined by calculating  values.
Markov Model
The lifetime costs and quality-adjusted
life-years (QALYs) rendered after ob-
taining true-positive, false-positive,
true-negative, and false-negative duplex
US results were derived by using a pre-
viously described Markov model (8).
These values included the costs and util-
ities associated with the subsequent
treatment, treatment complications,
and progression of disease that ensued
after these results were obtained. Sev-
eral health states were modeled for the
severity of neurologic disease (ie, tran-
sient ischemic attack, minor stroke, or
major stroke as a presenting condition
or a complication) in patients who ini-
tially had less than 50% stenosis, 50%–
69% stenosis, or 70%–99% stenosis.
Medical therapy, including aspirin treat-
ment, was assumed to be the optimal
treatment for patients with less than
50% stenosis. For patients with greater
than 50% stenosis, two criteria for ca-
rotid endarterectomy referral were
considered: 70%–99% stenosis and
50%–99% stenosis. We assumed that
the associated costs and life expectancy
after a carotid endarterectomy de-
pended on the presenting symptoms (ie,
transient ischemic attack or minor
stroke) rather than on the patient’s un-
derlying stenosis category before sur-
gery. Disease progression and death
were modeled by simulating transitions
to more severe health states during fol-
low-up. The Markov model was con-
structed by using DATA Pro 11.0 soft-
ware (TreeAge, Williamstown, Mass).
The lifetime costs and effects were inte-
grated into one measure, the net health
benefit (NHB), which is derived by using
the following equation:
NHB EQALY C/TWTP, (1)
where EQALY represents the lifetime ef-
fects in QALYs, C represents the life-
time costs, and TWTP is the amount that
society is willing to pay (ie, willing-to-
pay threshold) to save one QALY (10).
With this formula, we assumed two
threshold amounts that society would
be willing to pay to save one QALY:
$25 000 and $50 000 per QALY.
Recommended PSV Thresholds
The recommended PSV thresholds of
230 cm/sec for the diagnosis of 70%–
99% stenosis and 125 cm/sec for the
diagnosis of 50%–99% stenosis were
applied to our study data (7). For both
PSV thresholds, we calculated the asso-
ciated sensitivity and specificity.
Optimal PSV Threshold at Statistical
Analysis
We calculated the sensitivities and spec-
ificities associated with different PSV
thresholds by using DSA as the refer-
ence-standard examination. We used
two definitions of carotid artery disease,
which corresponded to the two indica-
tions for referring patients for carotid
endarterectomy: angiographically de-
termined 70%–99% stenosis and 50%–
99% stenosis. The cost-effectiveness
outcomes of the Markov model for the
50%–69% stenosis category were com-
bined with the results of either the 0%–
49% category or the 70%–99% cate-
gory (weighted for prevalence), de-
pending on the indication for carotid
endarterectomy. With use of ROC anal-
ysis, all combinations of sensitivity and
specificity were plotted on a graph on
which the y-axis represented sensitivity
and the x-axis represented 1  specific-
ity (11). Smooth ROC curves were cre-
ated by using summary ROC analysis
methods (12–14). For each combination
of sensitivity and specificity on the smooth
curves, the result-specific likelihood ratio
(LRRi)—that is, the probability (P) of a
specific test result (Ri) (eg, a PSV of 220
cm/sec) in the group with the disease
(DG) divided by the probability of that
specific test result (eg, 220 cm/sec) in the
group without the disease (NDG)—was
calculated and was equal to the tangent,




With the lifetime consequences of di-
agnostic testing and subsequent treat-
ment taken into account, the optimal like-
lihood ratio (LRopt) depends on the prev-
alence of disease (p) and the ratio of the
net loss due to false-positive test results
compared with true-negative results
(NHBTN  NHBFP) to the net loss due to
false-negative results compared with








The optimal combination of sensitiv-
ity and specificity (ie, the optimal oper-
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ating point) was derived from the
smooth ROC curve at the operating
point where the result-specific likeli-
hood ratio (Eq [2]) equaled the optimal
likelihood ratio based on the Markov
model (Eq [3]). Subsequently, we se-
lected the PSV value that was observed
to be closest to the operating point on
the smooth curve and defined it as the
optimal PSV threshold.
Sensitivity analysis of the preva-
lence of significant stenosis was per-
formed to evaluate the effect of this
prevalence on the optimal likelihood ra-
tio, sensitivity, specificity, and PSV
threshold. We used the SPSS 11.0 sta-
tistical software package (SPSS, Chi-
cago, Ill) to perform summary ROC
curve analysis and Excel 2000 (Mi-
crosoft, Redmond, Wash) to construct
the ROC curves.
Results
DSA and Duplex US Results
The symptomatic carotid artery could
be imaged and evaluated in 323 patients
with DSA and in 330 patients with du-
plex US. The results of both examina-
tions were available for 313 patients.
Values were missing owing to the fol-
lowing reasons: Sometimes it was not
feasible to perform both examinations
before surgery, some patients withdrew
from the study after having undergone
one examination, and the examination
was not always correctly performed ac-
cording to our study protocol. Also, oc-
casionally, the PSV was not measured
when duplex US was performed. Fi-
nally, in seven patients, it was impossi-
ble to measure the degree of stenosis
because of poor image quality and the
poor reliability of the DSA findings. In-
terobserver agreement calculated on
the basis of the DSA results for 170
patients was good (  0.79; 95% confi-
dence interval [CI]: 0.74, 0.84).
In Table 1, the categorized DSA and
duplex US results are cross tabulated.
At DSA, 0%–49% stenosis was de-
tected in 45 (14%) of 313 patients,
50%–69% stenosis was detected in 61
(20%), 70%–98% stenosis was de-
tected in 128 (41%), near occlusion (ie,
99% stenosis) was detected in 16 (5%),
and occlusion was detected in 63
(20%). Duplex US depicted occlusions
in 61 patients. The sensitivity and spec-
ificity of the duplex US–based diagnosis
of occlusion were 94% (59 of 63 pa-
tients; 95% CI: 88%, 100%) and 99%
(248 of 250 patients; 95% CI: 98%,
100%), respectively. There was slow
flow in combination with visualized se-
vere stenosis at duplex US, indicating
near occlusion, in 16 patients. In a total
of 236 patients, arteries that were nei-
ther occluded nor nearly occluded at
duplex US were assessable at ROC anal-
ysis.
The data in Figure 1, in which abso-
lute PSV measurements are plotted
against angiographic degrees of steno-
sis, show that the relationship between
PSV and stenosis degree is nonlinear. In
Figure 1a and 1b, the indications for
endarterectomy are set at minimal an-
giographic stenosis degrees of 70% and
50% (horizontal lines), respectively.
Shifting the PSV threshold (vertical
lines) to the left would result in an in-
versely related increase in the number
of true-positive test results and a de-
crease in the number of true-negative
test results. Thus, a decreased PSV
threshold is associated with higher sen-
sitivity and lower specificity. Con-
versely, shifting the PSV threshold up-
ward would result in lower sensitivity
and higher specificity.
Markov Model
Long-term outcomes of the cost-effec-
tiveness analysis (Table 2) indicate that
referring patients for carotid endarter-
ectomy instead of medical therapy re-
sulted in a loss in QALYs and an in-
crease in costs for patients with 0%–
49% stenosis. Performing endarterectomy
facilitated a small gain in QALYs and a
slight cost savings in patients with 50%–
69% stenosis and a relatively large gain in
QALYs and a large cost savings in patients
with 70%–99% stenosis (Table 2).
Recommended PSV Thresholds
The SRU has recommended using a PSV
of 230 cm/sec for the diagnosis of 70%–
99% stenosis and a PSV of 125 cm/sec
for the diagnosis of 50%–99% stenosis
(7). Applying the recommended thresh-
old of 230 cm/sec to diagnose 70%–
99% stenosis in our population would
result in a sensitivity of 95% (125 of 131
patients; 95% CI: 92%, 99%) and a
specificity of 51% (54 of 105 patients;
95% CI: 42%, 61%). If we applied a
threshold of 125 cm/sec to detect 50%–
Table 1




0%–49% 50%–69% 70%–98% 99% Occlusion Total
PSV (cm/sec)
0–124 16 1 0 0 0 17
125–230 20 17 5 1 0 43
230 8 42 117 8 1 176
Near occlusion 1 1 5 6 3 16
Occlusion 0 0 1 1 59 61
Total 45 61 128 16 63 313
Note.—Data are numbers of patients.
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99% stenosis in our study population,
the sensitivity would be 99% (190 of
191 patients; 95% CI: 98%, 100%) and
the specificity would be 36% (16 of 45
patients; 95% CI: 22%, 50%).
Optimal PSV Thresholds
For a referral for endarterectomy based
on an indication of 70%–99% stenosis,
the optimal result-specific likelihood ra-
tio based on the Markov model (calcu-
lated by using Eq [3]) was 0.21. Figure
2a shows the observed ROC curve and
the smooth ROC curve. Each dot on the
observed curve represents the sensitiv-
ity and 1  specificity of a specific PSV
threshold for the angiographic diagnosis
of 70%–99% stenosis—that is, for the
eligibility for endarterectomy. The opti-
mal likelihood ratio, or the slope of the
ROC curve, is illustrated in this figure.
The associated optimal sensitivity and
specificity were 97% (127 of 131 pa-
tients; 95% CI: 94%, 100%) and 48%
(50 of 105 patients; 95% CI: 38%,
57%), respectively. The optimal PSV
threshold that corresponded to this sen-
sitivity and specificity was 220 cm/sec
(Fig 2a). The optimal PSV threshold is
illustrated in Figure 1a also. The bottom
right quadrant of this figure shows the
large number of false-positive test re-
sults obtained by using the optimal PSV
threshold compared with the top left
quadrant, which contains a small num-
ber of false-negative test results ob-
tained by using the optimal PSV thresh-
old.
When 50%–99% stenosis was used
to indicate the need for endarterec-
tomy, the optimal result-specific likeli-
hood ratio was 0.38. The associated op-
timal sensitivity and specificity were
95% (182 of 191 patients; 95% CI: 92%,
98%) and 69% (31 of 45 patients; 95%
CI: 55%, 82%), respectively (Fig 2b).
The optimal PSV threshold that corre-
sponded to this sensitivity and specific-
ity was 180 cm/sec (Figs 1b, 2b).
Changing the willingness-to-pay
threshold from $25 000 to $50 000 per
QALY hardly affected the optimal likeli-
hood ratio and thus had no effect on the
optimal PSV threshold. When a higher
willingness-to-pay threshold is ac-
cepted, the NHB (Eq [1]) increases.
The ratio of the difference in NHBs as-
sociated with specific test results, how-
ever, changed only minimally when a
higher willingness-to-pay threshold was
used (Eq [3]).
The results of the sensitivity analysis
of the prevalence of disease are shown
in Table 3. The data in this table demon-
strate that when the prevalence of sig-
nificant stenosis increases, the optimal
likelihood ratio decreases and corre-
sponds to higher sensitivity, lower spec-
ificity, and a decreased optimal PSV
threshold. The data in Table 3 also show
that the prevalence of significant disease
(50%–99% stenosis) has to be very high
(approximately 90%) before the thresh-
old of 125 cm/sec recommended by the
SRU becomes optimal.
Discussion
We found that the optimal PSV thresh-
old for selecting symptomatic patients
for carotid endarterectomy was 220
cm/sec when the indication for endar-
terectomy was 70%–99% stenosis and
180 cm/sec when the indication was
Figure 1
Figure 1: Scatterplots of absolute PSV measurements and angiographic stenosis measurements. PSV thresholds for referring patients with (a) 70%–99% stenosis
(220 cm/sec) and (b) 50%–99% stenosis (180 cm/sec) for carotid endarterectomy are shown. Increasing the PSV threshold reduces the number of false-positive (FP)
cases (higher specificity) at the expense of a higher number of false-negative (FN) cases (lower sensitivity). TN true-negative cases, TP true-positive cases.
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50%–99% stenosis. The 220 cm/sec
threshold is similar to the threshold rec-
ommended by the SRU (230 cm/sec for
70%–99% stenosis), but 180 cm/sec is
higher than the recommended thresh-
old (125 cm/sec for 50%–99% stenosis)
(7).
The SRU based its recommenda-
tions on literature review findings. The
studies included in that review were fo-
cused on optimizing accuracy, and the
participating investigators did not take
into account the variable effects of false-
negative test results as opposed to the
effects of false-positive test results. The
results of our study show that referring
a patient with nonsignificant stenosis
(50%) for endarterectomy is more
harmful than missing a diagnosis of
50%–69% stenosis, and this finding ex-
plains the fairly high PSV threshold for
discriminating 50%–99% stenosis from
0%–49% stenosis.
The natural history of the disease to
be identified and the effectiveness of
treatment have a major role in deter-
mining the importance of sensitivity and
specificity. In cases of high-grade
(70%) carotid artery stenosis espe-
cially, undiagnosed disease is associated
with high monetary and life expectancy
costs (8). For the identification of pa-
tients with high-grade stenosis, duplex
US criteria should be highly sensitive,
yielding a minimal number of false-neg-
ative results, because these patients will
have high degrees of morbidity and
mortality if they are left untreated. The
overall losses associated with missing a
diagnosis in patients with 50%–99%
stenosis are smaller, because the bene-
fits associated with 50%–69% stenosis
are smaller than those associated with
70%–99% stenosis. Balancing the losses
and benefits led to a somewhat lower
optimal sensitivity and a higher optimal
specificity for the identification of 50%–
99% stenosis compared with the identi-
fication of 70%–99% stenosis.
The prevalence of significant steno-
sis in the population being evaluated
also has a critical role in defining the
optimal test criterion. In our study pop-
ulation, the prevalence of 70%–99%
stenosis was 46% and the prevalence of
50%–99% stenoses was 66%. Sensitiv-
ity analysis revealed that if the preva-
lence of significant stenosis were lower,
the derived slope would be steeper (Eq
[3]) and the optimal cutoff point on the
ROC curve would shift to the left, imply-
ing lower sensitivity, higher specificity,
and thus a higher PSV threshold.
Increasing the societal willingness-
to-pay threshold from $25 000 to
$50 000 per QALY did not influence the
choice of the optimal PSV threshold in
our study. However, this is not always
the case: The optimal likelihood ratio
can either increase or decrease—de-
pending on the proportions of true and
false results in a particular test situa-
tion—and thus lead to a higher or lower
threshold when the willingness-to-pay
threshold is increased.
Various methods of determining the
optimal diagnostic cutoff point on the
ROC curve have been reported in the
literature. Some investigators have used
the point on the curve that is closest to
the upper left corner in the ROC space
as the optimal cutoff point (18); others
have used the cutoff point associated
with a likelihood ratio of 1 (19). Other
methods include selecting the Q point—
that point where sensitivity equals spec-
ificity (20); maximizing accuracy, or the
sum of the sensitivity and specificity val-
ues (21,22); and accepting a preset level
of sensitivity (or specificity) and deter-
Table 2
Lifetime Costs, QALYs, and NHBs for Base Cases with Positive and Negative Duplex US Results for Several Stenosis Categories
Stenosis Prevalence and Treatment Scenario*
Stenosis Category
0%–49% 50%–69% 70%–99%
Prevalence 0.14 0.19 0.46
Negative US result, treatment with medical therapy
Cost ($) 30 599 36 427 46 444
No. of QALYs 11.36 11.09 10.71
NHB with $25 000 WTP per QALY 10.14 9.63 8.85
NHB with $50 000 WTP per QALY 10.75 10.36 9.78
Positive US result, treatment with carotid endarterectomy†
Cost ($) 35 638 35 638 35 638
No. of QALYs 11.12 11.12 11.12
NHB with $25 000 WTP per QALY 9.70 9.70 9.70
NHB with $50 000 WTP per QALY 10.41 10.41 10.41
Endarterectomy versus medical therapy
Change in cost ($) 5139 789 10 806
Change in no. of QALYs 0.24 0.03 0.41
Change in NHB with $25 000 WTP per QALY 0.44 0.06 0.85
Change in NHB with $50 000 WTP per QALY 0.34 0.05 0.63
Source.—Reference 8: modified data (from table 3) on treatment and follow-up of patients with TIA or stroke.
* WTP  willingness-to-pay threshold.
† Risks and prognosis following carotid endarterectomy were assumed to be independent of the underlying stenosis category.
EVIDENCE-BASEDPRACTICE:Duplex US for Indications of Carotid Endarterectomy Heijenbrok-Kal et al
Radiology: Volume 238: Number 2—February 2006 485
mining the corresponding specificity (or
sensitivity) (23). All of these methods
help to minimize the number of false-
positive and false-negative test results.
However, none of these methods in-
volves taking into account the prevalence
of disease or the consequences—in terms
of costs and quality of life—of correctly
or incorrectly classifying a test result as
positive or negative.
The decision analytic approach of
determining the optimal diagnostic
threshold that we used was described
many years ago (15). Published practi-
cal applications of this method, how-
ever, are scarce. In publications on ca-
rotid artery disease, we found only two
studies in which the investigators based
their optimal test criteria on patient
outcomes rather than test accuracy
(24,25). Wilterdink and co-workers
(24) based their criteria on the 2-year
mortality and morbidity rates associ-
ated with severe stenosis treated medi-
cally versus surgically, as reported in
the NASCET. They observed a slope, or
optimal likelihood ratio, of 0.09, which
is more lenient than the slope that we
observed and implies higher sensitivity
and lower specificity. They used duplex
US to select patients for angiography,
whereas we used duplex US to select
patients for endarterectomy.
The harm of performing unneces-
sary angiography in false-positive cases
in the Wilterdink et al study (24) was
much smaller than the harm of perform-
ing unnecessary endarterectomy in the
current study. In both the Wilterdink et
al study and the current study, however,
the harm of a false-negative test result
was the same: missing the opportunity to
reduce the probability of a carotid event
by means of endarterectomy. These fac-
tors explain the lower slope. Further-
more, we used updated results from the
NASCET study, which show a small but
significant benefit for patients with 50%–
69% stenosis; we integrated both costs
and effects on life expectancy; and we
modeled lifetime outcomes.
Kuntz et al (25) chose the PSV cut-
off point that minimized the probability
of stroke at 2 years for symptomatic
patients. They observed an optimal PSV
threshold of 229 cm/sec at one labora-
tory and 340 cm/sec at another labora-
tory. They did not report the optimal
likelihood ratio, or the slope of the ROC
curve. We did not evaluate the potential
differences between hospitals. Hospi-
tals that do have data on angiography
and PSV measurements, however,
could construct their own ROC curve
and determine their own optimal
threshold by using the optimal slope de-
rived from our decision analysis.
Our study population consisted of
patients with transient ischemic attack,
minor stroke, or amaurosis fugax. The
optimal PSV threshold may vary among
patients with different symptoms of ca-
rotid disease. We were unable to calcu-
late optimal PSV thresholds for each
subgroup of patients because the sub-
groups were too small for us to derive
accurate ROC curves with enough cutoff
values that were evenly spread along
the curve. Moreover, optimal PSV
thresholds may be different for asymp-
tomatic patients, because the associ-
ated costs and consequences of testing
and treatment for these patients differ
from those for symptomatic patients.
Figure 2
Figure 2: Observed (ie, original) and smooth ROC curves for indications of (a) 70%–99% and (b) 50%–99% stenoses. The optimal likelihood ratio (LR)—that is, the
slope of the ROC curve— derived at cost-effectiveness analysis is indicated with the associated sensitivity, specificity, and optimal PSV threshold. These data show that
the optimal operating point on the ROC curve based on cost-effectiveness analysis results is different from the point on the curve that is closest to the upper left corner in
ROC space, which is based on maximal accuracy.
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For the estimation of ROC curves,
the test variable needs to be a measure
that continuously increases or de-
creases with the severity of disease. The
PSV, however, increases with the sever-
ity of stenosis but decreases with near
occlusion and is absent with total occlu-
sion; therefore, we had to exclude these
conditions. This was justified in the
cases of total occlusion, because carotid
endarterectomy is not indicated for to-
tally occluded arteries. Duplex US was
most accurate for the diagnosis of the
total occlusions but not very accurate
for the diagnosis of the near occlusions.
Overall, excluding the near and total oc-
clusions did not result in an overestima-
tion of the diagnostic accuracy of duplex
US.
Currently, new noninvasive tests
that yield excellent images of the carotid
arteries, such as CT angiography and
MR angiography, are available (26).
With the availability of these examina-
tions, preoperative carotid angiography
is hardly needed anymore. However,
these new examinations are not yet ac-
cepted as reference-standard tests;
therefore, we used carotid angiography
as the reference-standard test in our
ROC analyses.
Furthermore, we took into account
no velocity parameters except the PSV.
In several studies, it has been shown
that the PSV in the internal carotid ar-
tery is the best single velocity parame-
ter for quantifying stenosis (27,28). In
clinical practice, multiple clinical pa-
rameters could be combined to account
for differences in patients and to decide
which patients should undergo carotid
endarterectomy.
In our analyses, we used a decision
analytic model to calculate the harms
and benefits of diagnostic testing and
subsequent treatment. This model is a
simplification of reality. The input vari-
ables came from multiple sources, as-
sumptions had to be made, and uncer-
tainty surrounded the input variables.
Thus, when new therapies become
available, the model may need to be
changed. For example, our calculations
are based on the use of aspirin as the
optimal medical therapy for symptom-
atic patients with less than 50% steno-
sis, in accordance with the NASCET and
European Carotid Surgery Trial proto-
cols. However, these patients are in-
creasingly being treated with statins and
clopidogrel also. Therefore, the diag-
nostic thresholds need to be updated
when data on the long-term effects of
statins and clopidogrel in these patients
become available.
In conclusion, on the basis of the
lifetime consequences of diagnostic test-
ing and subsequent treatment, the opti-
mal PSV threshold was 220 cm/sec for
the diagnosis of 70%–99% carotid ar-
tery stenosis and 180 cm/sec for the
diagnosis of 50%–99% stenosis in pa-
tients with amaurosis fugax, transient
ischemic attack, or minor stroke when
duplex US was used to refer patients for
carotid endarterectomy.
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